BEBT-809

N/A

Report date: 2025/02/24 11:37:44
NMEFirst In Class

Base Information

Drug NameBEBT-809
Drug Alias NameBEBT-809
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable G-protein coupled receptor 75 inhibitors20-hydroxyeicosatetraenoic acid synthesis inhibitors
TargetsProbable G-protein coupled receptor 7520-hydroxyeicosatetraenoic acid
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou BeBetter Medicine Technology Co
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou BeBetter Medicine Technology Co
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A